Center for Drug Research and Development

CDRD, CDRD Ventures, GSK collaborate to advance Canadian health research

Friday, June 1, 2012

The Center for Drug Research and Development (CDRD), its commercial arm, CDRD Ventures (CVI), and global pharmaceutical company GlaxoSmithKline (GSK) in have entered into a strategic collaboration that will provide new financial resources as well as leading drug development expertise to be applied to the development and commercialization of health research conducted in Canadian research institutions.

[Read More]